OUR NATIONAL PENSION FUND
Lendlease and CPP Investments Reinforce Their Build-to-Rent Partnership

Canada Pension Plan Investment Board


LONDON, UK, June 26, 2020 /CNW/ - Lendlease and Canada Pension Plan Investment Board (CPP Investments) are continuing to strengthen their partnership in the Build-to-Rent sector in the United Kingdom. Today both parties confirmed that they have agreed another £85m of investment to help fund 123 new Build-to-Rent homes at Elephant Park in south London.

This is the second major investment between the organisations this year. In February, they announced an £80m investment to begin construction of an 18-storey building with 118 Build-to-Rent homes at Elephant Park.

Build-to-Rent continues to establish itself as an institutional real estate sector in the UK, and the partnership between Lendlease and CPP Investments was first announced in 2018 when they agreed an initial target of investing £1.5 billion in the sector. Lendlease will develop, construct and manage the Build-to-Rent homes on behalf of the partnership. With this latest investment, CPP Investments and Lendlease will each invest 50%.

Victoria Quinlan, Managing Director for Investment Management Europe at Lendlease, said: "Partnering with CPP Investments builds momentum in our Build-to-Rent platform and provides much needed housing in London. The investment demonstrates a vote of confidence not just in the Build-to-Rent sector in London, and the Elephant Park development, but in the attractiveness of the UK as a global investment destination. We highly anticipate the successful launch of our first Build-to-Rent homes at Elephant Park later this year."

Andrea Orlandi, Managing Director, Head of Real Estate Europe, CPP Investments, said: "The Build-to-Rent Sector in the UK continues to be supported by long term trends, particularly in London and other major UK cities. Private rentals are an increasingly attractive and flexible option for households. The Elephant Park project continues to move ahead towards completion for the first phase, and our, and our latest financial commitment will help to progress this landmark regeneration project. It also extends our positive, broader relationship with Lendlease, which seeks to identify further investment and regeneration development opportunities in the UK."

Today's announcement means that the partnership is now planning to provide over 900 Build-to-Rent homes at Elephant Park. Construction is well underway on the first two buildings and later this year the partnership is expected to confirm timings for their completion and opening to residents. Within both buildings, residents who choose to rent through the Build-to-Rent scheme will enjoy a personalised, customer focussed renting experience, unlike any other.

Lendlease is working in partnership with Southwark Council to deliver Elephant Park, a £2.5 billion regeneration project. Investment like this, from partners such as CPP Investments, enables the project to continue at pace, whilst creating thousands of high-quality new homes including the delivery of affordable housing, jobs, business opportunities and green space for Londoners as promised from the outset.

About Lendlease
Lendlease is a leading international property and infrastructure group with operations in Australia, Asia, Europe and the Americas. Our vision is to create the best places - places that inspire and enrich the lives of people around the world.
Headquartered in Sydney, Australia, and listed on the Australian Securities Exchange, Lendlease has approximately 12,350 employees internationally.
Our core capabilities are reflected in our operating segments of Development, Construction and Investments. The combination of these three segments provides us with a sustainable competitive advantage and allows us to provide innovative integrated solutions for our customers.

Visit www.lendlease.com or follow us on Twitter @Lendleaseuk.

About CPP Investments
Canada Pension Plan Investment Board (CPP Investments™) is a professional investment management organization that invests the funds not needed by the Canada Pension Plan (CPP) to pay current benefits in the best interests of 20 million contributors and beneficiaries. In order to build diversified portfolios of assets, investments in public equities, private equities, real estate, infrastructure and fixed income instruments are made by CPP Investments. Headquartered in Toronto, with offices in Hong Kong, London, Luxembourg, Mumbai, New York City, San Francisco, São Paulo and Sydney, CPP Investments is governed and managed independently of the Canada Pension Plan and at arm's length from governments. At March 31, 2020, the CPP Fund totalled $409.6 billion. For more information about CPP Investments, please visit www.cppinvestments.com or follow us on LinkedIn, Facebook or Twitter.

SOURCE Canada Pension Plan Investment Board

For further information: Hetty Crist, Head of External Communications, Lendlease Europe, Email: hetty.crist@lendlease.com, Phone: 07719 986 846; Jonathan Edwards, General Manager, Corporate Communications, Lendlease Europe, Email: jonathan.edwards@lendlease.com, Phone: 07753 581 086; Steve McCool, Director, Corporate Communications, CPP Investments, Email: smccool@cppib.com, Phone: +44 20 3947 3002
Related Links

www.cppib.ca


Organization Profile

Canada Pension Plan Investment Board


Also from this source


CPP Investments Net Assets Total $409.6 Billion at 2020 Fiscal...


CPP Investments commits €200 million to Renewable Energy Projects ...


IDEAL, CPP Investments and Ontario Teachers' Complete the...

Ethnicity Matters New Survey: COVID-19, Economy and Diversity

Recovery depends strongly on reaching multicultural Canada, research shows
TORONTO, June 26, 2020 /CNW/ - New research shows how important it is to understand diverse, multicultural Canadians to strengthen the post-COVID-19 economic recovery.

The research — a new survey of nearly 1,000 Canadians during the height of the pandemic — shows significant variations between South Asian Canadians, Chinese Canadians and the general population in what people hope to or intend to purchase now and after the lockdowns end.1

Among the distinctions:
Canadians from diverse communities are more concerned than the general population about the quality of Canada's online services, about crime, about managing online banking — and about racism.

In the coming year 14 per cent of South Asians and 12 per cent of Chinese Canadians say they're likely to buy a house or condo — and significantly more plans to move by downsizing, upsizing or buying a first home


South Asian and Chinese Canadians buying patterns are often different from the general population — for example, approximately one in five South Asians plan to buy smartphones, laptops, tablets or TVs in the next 12 months

Manufacturers, retailers and the auto industry should take notice — about one in five South Asian and Chinese Canadians say they're likely to renovate their homes or buy vehicles within the year

Grocers and food producers should pay attention too — South Asian and Chinese Canadians are quite specific about what household and grocery items they prefer and plan to buy, in many cases more specific than the general population

Saving, investing and insurance-buying patterns are significantly higher for South Asian and Chinese Canadians

"This survey offers important in-depth insight into key consumer patterns among Canadians during an unprecedented time," says Bobby Sahni, Partner and Co-Founder of Ethnicity Matters, which commissioned the research.

"To us, the research offers three important messages. One, South Asian and Chinese Canadians will be key to our recovery. Two, businesses will benefit if they recognize and celebrate the distinctions among different multicultural communities," says Howard Lichtman, Partner and Co-Founder of Ethnicity Matters.

"And thirdly, businesses will do well to keep their eyes on what diverse communities say they want — types of groceries and home products, electronics, cars and trucks, homes, renovation materials and financial services including insurance," Lichtman said. "Those wants and needs are likely going to be at the heart of the post-COVID-19 recovery."

Socially distant interviews available!

Ethnicity Matters is Canada's leading authority in multicultural marketing and communications. We are a full-service business solutions company, dedicated to driving sales and growth for clients by connecting them to the flourishing ethnic and new immigrant communities, both at home and around the world. 

 For more information, visit EthnicityMatters.com
_________________________

1 Survey was conducted April 13-27, 2020 among 900 respondents within Canada — 300 from South Asian and Chinese communities and general population respectively. The margin of error for the general gopulation, South Asians, Chinese respondents (at a 90 per cent confidence level) is plus or minus 4.75 per cent for each

SOURCE Ethnicity Matters

For further information: Howard Lichtman, howard@ethnicitymatters.com, 416.402.4948 ; Bobby Sahni, bobby@ethnicitymatters.com, 416.277.2033

Organization Profile

Ethnicity Matters

New footage from World Animal Protection shows cruel elephant training for tourist entertainment

World Animal Protection


TORONTO, June 26, 2020 /CNW/ - As the economy starts to reopen and we approach our "new normal", some may already be thinking about their next travel adventure and the possibility of getting up close to wild animals or seeing them perform. Global charity, World Animal Protection is urging tourists to make sure they do this ethically, as many are not aware of what goes on behind the scenes to train wild animals.

This undercover video exposes the hidden reality of the physical and psychological trauma of elephant training for tourist entertainment - a lifetime of horror for a "once in a lifetime" travel experience. Credit: World Animal Protection
VIDEO AT THE BOTTOMUnseen footage released by the charity shows parts of the cruel training process, sometimes known as 'the crush', that young elephants endure to make them submissive enough to interact with people.

In the video young elephants are forcibly taken from their mothers, tied to wooden structures for days, forced to walk in chains and beaten.

World Animal Protection is calling on the travel industry to build back better before tourism resumes in Thailand and other holiday destinations. And to commit to end the exploitation of elephants and other wild animals for tourist entertainment.

"This is the ideal opportunity for the travel industry to cut its ties with the wildlife trade and rebuild responsibly," says Melissa Matlow of World Animal Protection Canada. "Elephants are still being poached from the wild to supply the demand from tourists to ride them. Regardless of whether the elephants are captured from the wild or bred in captivity, all elephants used for rides are cruelly trained and this must stop now to end animal suffering and protect elephants in the wild."

There are approximately 2,800 captive elephants in camps across Thailand, who have undergone this cruel training. The disturbing footage was captured to document the most common techniques used to break the elephant's spirits. This includes the use of a bull-hook – a metal tool used to jab sensitive areas, chains to restrain them and frequent exposure to stressful situations. This horrific treatment of elephants is to make them submissive enough to be used for performing, riding, bathing, and other tourist interactions. Tourism drives the demand for elephant experiences, and trainers are forced to deploy these methods.

With the industry coming to a standstill during the pandemic, at least 85 elephant camps in Thailand were forced to close, laying off over 5,000 staff. The remaining camps are still struggling to look after their elephants. World Animal Protection has been providing essential funds for 13 ethical, elephant-friendly camps across Asia to help them through this difficult time.

As a sustainable, long-term solution, the charity is advocating for a ban on breeding elephants for tourism entertainment to ensure future generations are spared this trauma. Travel companies also hold considerable power to turn their backs on unethical practices and can opt instead to support elephant-friendly camps, where tourists see elephants from a safe distance.

For most elephants, being released back into the wild is not possible, so an elephant-friendly camp is their best option. These camps still provide jobs to local people such as elephant keepers, known as mahouts. Elephants are given the freedom to behave naturally , rather than being used for strenuous rides and kept in chains.

More than 250 travel companies have pledged not to sell elephant rides and shows. This includes Intrepid, G Adventures, World Expeditions and the Travel Corporation who have adopted progressive animal welfare policies and are working with World Animal Protection to encourage the travel industry to change.

World Animal Protection is calling on other Canadian travel companies to join and take responsibility to end the exploitation of elephants and other wild animals forever.

The charity also encourages everyone to support a complete global ban of the wildlife trade, which inflicts suffering on millions of animals daily.

About World Animal Protection

From our offices around the world, including, Brazil, Kenya, the US and Canada, we move the world to protect animals. Last year, we gave more than 3 billion animals better lives through our campaigns that focus on animals in the wild, animals in disasters, animals in communities and animals in farming. For more information visit https://www.worldanimalprotection.ca

SOURCE World Animal Protection

For further information: Notes to editors: For an interview with a spokesperson or for more b-roll, images contact Nina Devries - ninadevries@worldanimalprotection.ca or 437-970-6565

Organization Profile

World Animal Protection


Also from this source


World Animal Protection Calls on G20 Leaders to Help Prevent...


World Animal Protection Says COVID-19 Shines Light on a Broken...


World Animal Protection Launches Emergency Appeal for Elephants...

Supreme Court of Canada Rules Against Uber in $400M Class Action, Delivers Historic Win for Employees
Samfiru Tumarkin LLP

TORONTO, June 26, 2020 /CNW/ - Today, the Supreme Court of Canada issued a historical decision on a class action lawsuit against Uber that preserves employee rights across the country.

The court found that, in the case of Heller v. Uber Technologies Inc., the $400 million lawsuit must be heard in Ontario, and not through international arbitration in the Netherlands as proposed by Uber.

"The Supreme Court of Canada's message is very clear: if you wish to operate in this country, you have to be prepared to abide by the laws of Canada and adhere to the jurisdiction of its courts," said employment lawyer Lior Samfiru of Samfiru Tumarkin LLP, who commenced the class action in 2017 on behalf of Uber drivers.

The lawsuit alleges that the drivers were employees at law, that they were misclassified as independent contractors by Uber, and were therefore owed various entitlements under Ontario and Canadian employment laws.

The issue before The Supreme Court of Canada was whether Uber was able to require its drivers to arbitrate any and all disputes in the Netherlands. Upon signing up with Uber, drivers were required to sign a document purporting to require them to raise any dispute with Uber before an international arbitration in Amsterdam. Uber, therefore, tried to have the lawsuit dismissed saying the drivers cannot proceed with legal action in Canada but must file individual arbitrations in a foreign country.

The concern with Uber's position was that, if a company can require its workers to only raise dispute in a foreign jurisdiction, no worker would actually take such a step, which would allow a company to do whatever it wanted, without repercussions.

"A win for Uber would have effectively ended employee rights in this country," said Samfiru. "The Supreme Court of Canada was well aware of this issue and determined that a company operating in Canada must abide by Canadians laws and cannot eliminate employee rights by imposing the laws of a foreign jurisdiction."
The Supreme Court reiterated that employees and all workers continue to have access to legal tribunals and Canadian courts in order to enforce their rights.

"After all, all the legal rights in the world are of no value if there is no way to enforce them. For a company to try to require employees to give up the laws of Canada is unconscionable and offends our sense of fairness and common sense," said Samfiru.

Uber now will have to address the claims of the drivers that they are employees and have been misclassified for many years.

About Samfiru Tumarkin LLP

Samfiru Tumarkin LLP is an employment law firm that specializes in severance pay, wrongful dismissal, denied long term disability claims, constructive dismissal, employee misclassification, human rights law, labour law, temporary layoffs and employment contracts.

The firm represents both employees and employers across Ontario and British Columbia, as well as individuals who have been denied their long-term disability payments by the insurance company. It has successfully represented tens of thousands of clients in Ontario and BC combined, and is the most positively reviewed employment law firm in Canada (on Google).

SOURCE Samfiru Tumarkin LLP

For further information: Lior Samfiru, Partner at Samfiru Tumarkin LLP, lior.samfiru@stlawyers.ca, 416-216-5900; or Ryan Bonnar, Media Relations Manager at Samfiru Tumarkin LLP, ryan.bonnar@stlawyers.ca, 416-216-5893
Related Links

http://stlawyers.ca/toronto/

Lack of Access to Vision Loss Costs Canadians $19 billion per year

Canadian Ophthalmological Society

OTTAWA, ON, June 26, 2020 /CNW/ - Despite concerted action over the past 30 years, Canadian and health systems worldwide face significant challenges in meeting the current and projected eye care needs.

Vision loss costs Canadians $19 billion/year and the impact of major eye diseases and trauma disproportionately impact minority communities in Canada. The federal government signed the World Health Organization's first resolution on Universal Eye Health that will be presented at the next World Health Assembly this year, however, Canada has not taken any action to increase vision health access in our country.

The Canadian Ophthalmological Society (COS) hosted the national launch of the World Health Organization's first World Report on Vision is calling upon the Canadian government to take action. "The federal government should extend universal access to government-funded eye services for Canadians of all ages; to eliminate barrier to access for medically necessary eye drugs; eliminate drug shortages for critical eye care medicines; and expand public infrastructure for tele-ophthalmology," Said Dr. Yvonne Buys, President of the COS, "Still too many Canadians suffer from preventable or treatable vision loss at a substantial cost to them individually and us as a society."

World Health Organization's first World Report on Vision outlines the magnitude of the problem where at least 1 billion people around the world currently live with vision loss that could have been prevented. The WHO has called for governments to make eye care an integral part of universal health coverage; implement integrated people-centred eye care in health systems; promote high-quality research; monitor trends and evaluate progress; raise awareness, and engage and empower people and communities.

About the Canadian Ophthalmological Society
The Canadian Ophthalmological Society (COS) is the national, recognized authority on eye and vision care in Canada. As eye physicians and surgeons, we are committed to assuring the provision of optimal medical and surgical eye care for all Canadians by promoting excellence in ophthalmology and by providing services to support our members in practice. Our membership includes over 900 ophthalmologists and 200 ophthalmology residents. We work collaboratively with government, other national and international specialty societies, our academic communities (ACUPO), our provincial partners and affiliates and other eye care professionals and patient groups to advocate for health policy in Canada in the area of eye and vision health. COS is an accredited, award-winning provider of Continuing Professional Development (CPD) through the Royal College of Physicians and Surgeons of Canada (RCPSC) and is an affiliate of the Canadian Medical Association (CMA). For more information, visit cos-sco.ca.

SOURCE Canadian Ophthalmological Society

For further information: The PR Department Inc., Cell: 416-948-7417, medias@prdepartment.ca

Organization Profile

Canadian Ophthalmological Society


Also from this source


Vision Health and Covid-19 Update from the Canadian...

Vancouver-based NGO Backs the Call for Canadian Government to Increase Equitable Access to Eye Care as Recommended by the World Health Organization's First-ever World Report on Vision 

Seva Canada Society

VANCOUVER, BC, June 26, 2020 /CNW/ - Vancouver-based eye care charity, Seva Canada, co-hosted the launch of the World Health Organization's (WHO) first World Report on Vision in Canada on June 26, 2020. The cost of vision loss to Canadians is $19 billion/year and affects all elements of our economy. Costs are expected to rise to $30.3 billion/year by 2032 with the overall single largest indirect cost being lost productivity. Canada, a signatory to the WHO's first resolution on Universal Eye Health has not taken any significant action to address vision health. Seva Canada, along with the Canadian eye care community, called upon the Canadian government to take a leadership role to implement the recommendations of the World Health Organization's first World Report on Vision, launched by the Director-General Dr. Tedros Adhanom Ghebreyesus.

Despite concerted action over the past 30 years, health systems in Canada and worldwide, face significant challenges meeting current and projected eye care needs. Globally more than 2.2 billion people have vision impairment and of those, at least 1 billion have vision impairment that could have been prevented or has yet to be treated. The burden of most eye conditions and vision impairment is not borne equally. It weighs more heavily on low- and middle-income countries, on rural communities, on older people, women, people with disabilities, ethnic minorities and indigenous populations.

With global demand for eye care set to triple by 2050 due to population growth, ageing and changes in lifestyle, recommended actions based on the Word Report on Vision hope to avoid a considerable challenge to Canadian and health systems worldwide.

"Seva Canada is reassured that the WHO is stimulating action to meet growing eye care needs in Canada and globally through an integrated people-centred approach. We know that poverty reduction and the overall health of populations rely on equitable access to eye care. Over the past 38 years, our award-winning development model has been creating sustainable eye care programs in low-income countries with local partners to reach marginalized populations most in need – women, children and people living in extreme poverty and isolation. Everything we do, from training to providing supplies to conducting research and funding surgery, glasses and medicine, is for one reason: to provide communities with access to high-quality care that will restore sight and prevent blindness, now and in the future. When you give people the power of sight, you also give access to education, employment and the foundation for a better life." says Penny Lyons, Seva Canada Executive Director.

Seva Canada and the Canadian eye care community is advocating for the federal and provincial governments to provide universal access to government-funded eye services for Canadians of all ages; to eliminate barriers to access for medically necessary eye medications; eliminate drug shortages for critical eye medications; and to expand public infrastructure for telemedicine for vision care which can provide access to care amongst our rural and indigenous populations.

"People who need eye care must be able to receive high-quality interventions without suffering financial hardship. It is time to make sure that as many people as possible in all countries can see as well as current health technologies and health systems allow." says Director-General Dr. Tedros Adhanom Ghebreyesus.

About Seva Canada: Seva Canada (seva.ca) is a Vancouver-based charitable organization that restores sight and prevents blindness in developing countries. Since 1982, Seva has given over 5 million people the power of sight through life-changing surgeries and provided eye care services including glasses and medicine to millions more.

Seva works with local partners to create sustainable eye care programs that achieve long-term change, are culturally sensitive and reach those most in need – women, children and people living in extreme poverty and isolation. Registered charity #13075 4941 RR0001

SOURCE Seva Canada Society http://www.seva.ca

Government of Canada announces emergency support for Vancouver Aquarium

Funding to Ocean Wise Conservation Association will help ensure the survival of this important tourist attraction and over 70,000 marine animals

Western Economic Diversification Canada 

VANCOUVER, BC, June 26, 2020 /CNW/ - The COVID-19 pandemic has had a significant impact on organizations of all sizes, forcing the closure of important businesses and tourist attractions across Canada. These closures have hurt revenues and forced many to issue layoffs and make difficult choices. That's why the Government of Canada has taken strong action to protect jobs, stabilize our economy and provide relief through this difficult period.

$2 million to support essential services at the Vancouver Aquarium and ensure the survival of 70,000 resident marine animals (CNW Group/Western Economic Diversification Canada)

As it reopens to visitors, Terry Beech, Parliamentary Secretary to the Minister of Fisheries and Oceans and the Canadian Coast Guard, on behalf of the Honourable Mélanie Joly, Minister of Economic Development and Official Languages, and Minister responsible for Western Economic Diversification Canada, today announced emergency federal support for the Vancouver Aquarium.

Federal support for iconic BC tourist attraction affected by COVID-19

Totaling $2 million, this federal funding will support essential services at the aquarium, assisting it through the recovery period. This will help it to reopen to visitors, cover operational costs and ensure the survival of its marine animals.

Operated by the Ocean Wise Conservation Association, the Vancouver Aquarium has been an iconic BC attraction for over 60 years, thrilling residents of the Lower Mainland and tourists from around the world. Yet COVID-19 has resulted in its closure over the past few months, hurting revenues, imperiling jobs and threatening the aquarium's ability to provide for the thousands of animals in its care.

The Government of Canada is committed to providing the support and resources needed to ensure that British Columbia remains a world-leading tourist destination.

Quick facts:
Operated by the OWCA, the Vancouver Aquarium is a marquee tourist attraction offering a rich mixture of marine conservation, education and scientific programming, and is Canada's only marine mammal rescue facility.
The Vancouver Aquarium is home to thousands of ocean species, including rescued seals, sea lions and otters.
According to Destination BC, the tourism industry in British Columbia generated $20.5 billion in revenue in 2018 and employed 161,500 people.

Quotes

"From majestic sharks to adorable sea lions, it's not hard to see why the Vancouver Aquarium is one of British Columbia's most beloved tourist attractions. While COVID-19 has had a serious impact on tourism, this significant support from Western Economic Diversification Canada will help the aquarium keep delighting visitors from across the Lower Mainland and around the world. Our message to the tourism industry is clear: we're working with you to support good jobs and help BC tourism come back strong."
- The Honourable Mélanie Joly, Minister of Economic Development and Official Languages, and Minister responsible for Western Economic Diversification Canada

"Before the COVID-19 pandemic began, over 1 million visitors a year experienced the rich mixture of education and scientific programming offered by the Vancouver Aquarium. This funding will allow the Ocean Wise Conservation Association to continue inspiring the next generation of environmental stewards while providing the critical conservation work that keeps our oceans safe."
- Terry Beech, Parliamentary Secretary to the Minister of Fisheries and Oceans and the Canadian Coast Guard and Member of Parliament for Burnaby North – Seymour

"British Columbia's tourism sector has been hard hit by COVID-19 pandemic and needs help to recover in time for Canadians to explore their communities this summer and beyond. That is why we are providing targeted support to facilities like the Vancouver Aquarium that help attract visitors and support our local economy. We will continue to make every effort to keep Canadians safe while helping communities rebuild in the post-COVID-19 economy."
- Terry Duguid, Parliamentary Secretary to the Minister of Economic Development and Official Languages (Western Economic Diversification Canada) and to the Minister of Environment and Climate Change (Canada Water Agency)

"Ocean Wise is very grateful to the federal government for this emergency funding. Since closing the not-for-profit Vancouver Aquarium in March due to COVID-19, we lost almost all revenues while still being faced with more than $1 million a month in animal care and facility costs. We are still fighting for the Vancouver Aquarium's long-term survival, but this support from Western Economic Diversification Canada is crucial. We are hopeful that the community will continue to support the 64-year-old Vancouver Aquarium, by buying a ticket and coming back to visit us, once we reopen to the public on June 26th."
- Lasse Gustavsson, President and CEO, Ocean Wise Conservation Association

Additional links
Ocean Wise Conservation Association
Vancouver Aquarium

Follow the department on Twitter: @WD_Canada

WD Homepage
WD Toll-Free Number: 1-888-338-WEST (9378)
TTY (telecommunications device for the hearing impaired): 1-877-303-3388

IF THERE IS A DISCREPANCY BETWEEN ANY PRINTED VERSION AND THE ELECTRONIC VERSION OF THIS NEWS RELEASE, THE ELECTRONIC VERSION WILL PREVAIL.

SOURCE Western Economic Diversification Canada

For further information: Alexander Cohen, Press Secretary, Office of the Minister of Economic Development and Official Languages, alexander.cohen@canada.ca; Amanda Costa, A/Regional Communications Manager, Western Economic Diversification Canada, Vancouver, British Columbia, 604-603-9480, amanda.costa@canada.ca
Related Links

http://www.wd.gc.ca/


Organization Profile

Western Economic Diversification Canada


Also from this source


COVID-19: Canadian Seafood Stabilization Fund opens June 22, 2020 ...


Western Economic Diversification Canada working with tourism...


COVID-19: Western Economic Diversification Canada launches...

CANADA HOME OF PSYCHEDELICS SINCE 1948
MindMed Building Diverse Pipeline and Leadership Position in Psychedelic Inspired Medicines Industry




Mind Medicine (MindMed) Inc.

MindMed Co-founders and Co-CEOs JR Rahn and Stephen Hurst to provide corporate update of activities and investor Q&A on July 2, 2020 at 1pm EDT

NEW YORK, June 26, 2020 /CNW/ -- MindMed, the leading neuro-pharmaceutical company for psychedelic inspired medicines is rapidly advancing its drug development pipeline and R&D activities since its listing on March 3, 2020.

MindMed Co-Founder and Co-CEO JR Rahn said, "Our progress in the past few months clearly demonstrates the quality of our team and the pace at which we operate as a company. We are honored to pioneer the fast growing psychedelic inspired medicines industry alongside peers including COMPASS Pathways, ATAI Life Sciences and non-profits MAPs, USONA and the Heffter Institute. There is a very clear distinction of the caliber of organizations advancing clinical trials to develop disruptive medicines for mental health and addiction and we look forward to continually raising the bar for the entire space and patients."

In furtherance of its mission to discover, develop and deploy psychedelic inspired medicines the company and management have executed on the below selected opportunities since listing on March 3, 2020:

LSD (lysergic acid diethylamide)
Experiential Therapies
Added an ongoing Phase 2 clinical trial evaluating high dose LSD for the treatment of anxiety disorders in collaboration with the University Hospital Basel's Liechti Lab.
Initiated Project Lucy, a high dose LSD psychedelic assisted therapy drug commercial development program for the treatment of anxiety disorders, intending to undertake a Phase 2b human trial.
Added and began treating patients in a Phase 2 clinical trial of LSD for Cluster Headaches in collaboration with University Hospital Basel's Liechti Lab.
Filed a patent application for a LSD neutralizer technology intended to shorten and stop the effects of an LSD trip during a therapy session in collaboration with the University Hospital Basel's Liechti Lab.
Acquired the exclusive license to 8 clinical trials and human safety studies of LSD at University Hospital Basel evaluating LSD.
Filed a patent application and are developing technologies and analytics that seek to personalize LSD assisted therapy experiences for a specific patient in collaboration with University Hospital Basel Liechti Lab.

Microdosing Division
Entered into a clinical trial agreement with Maastricht University to undertake a Phase 2a clinical trial for microdosing LSD in adult patients with ADHD intending to begin by the end of 2020.
Appointed Principal Investigators for Phase 2a clinical trial for microdosing LSD Dr Kim Krupyers (Maastricht University) and Dr Matthias Liechti (University Hospital Basel).
Added additional clinical trial site at University Hospital Basel for Phase 2a clinical trial at University Hospital Basel.

18-MC (Opioid Use Disorder Program)Initiated and began dosing of a Phase 1 human safety trial of our 18-MC program for Opioid Use Disorder in Australia in the midst of COVID-19.

MDMA (3,4-Methylenedioxymethamphetamine)
Acquired the exclusive license to 9 completed clinical trials of MDMA at University Hospital Basel. Performing ongoing evaluation of data and opportunities to create new drug development programs to include MDMA
Filed a patent application and are developing technologies and analytics that seek to personalize MDMA assisted therapy experiences for a specific patient in collaboration with University Hospital Basel Liechti Lab.

DMT (N,N-Dimethyltryptamine, active ingredient in Ayahuasca)
Providing startup funding to Liechti Lab for a Phase 1 clinical trial of DMT testing various intravenous dosing regimens, expected to begin in Q4 of 2020 setting stage for future potential Phase 2a proof of concept trials

Corporate Development
Appointed Johns Hopkins Professor and leading psychedelics researcher, Matt Johnson to its scientific advisory board

MindMed Co-Founders and Co-CEOs will provide an update on operations and corporate activities, and will answer questions for shareholders on Thursday, July 2 at 1pm EST. Please sign up for Webinar here:

https://us02web.zoom.us/webinar/register/WN_pOzqk58eQaqgq_UZExDiHg

When: Jul 2, 2020 01:00 PM Eastern Time (US and Canada)
After registering, you will receive a confirmation email containing information about joining the webinar.

About MindMed

Mind Medicine (MindMed) Inc. is a neuro-pharmaceutical company that discovers, develops and deploys psychedelic-inspired medicines to improve health, promote wellness and alleviate suffering. The company's has initiated or is initiating studies to evaluate potential treatments to help patients with ADHD, anxiety, cluster headaches and substance abuse. The MindMed executive team brings extensive biopharmaceutical industry experience to this groundbreaking approach to the development of next-generation psychedelic medicines. MindMed trades on the NEO Exchange under the symbol MMED. MindMed can also be traded in the US under the symbol OTC: MMEDF and in Germany under the symbol DE:BGHM. For more information: www.mindmed.co.

MindMed Forward-Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Mind Medicine (MindMed) Inc. ("MindMed" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying word. These statements concern, and these risks and uncertainties include, among others, MindMed's and its collaborators' ability to continue to conduct research and clinical programs (including those discussed in this press release), MindMed's ability to manage its supply chain, net product sales of products marketed by MindMed and/or its collaborators (collectively, "MindMed's Products"), and the global economy; the nature, timing, and possible success and therapeutic applications of MindMed's Products and product candidates and research and clinical programs now underway or planned; the likelihood, timing, and scope of possible regulatory approval and commercial launch of MindMed's product candidates and new indications for MindMed's Products; unforeseen safety issues resulting from the administration of MindMed's Products and product candidates in patients, including serious complications or side effects in connection with the use of MindMed's Products and product candidates in clinical trials; determinations by regulatory and administrative governmental authorities which may delay or restrict MindMed's ability to continue to develop or commercialize MindMed's Products and product candidates; ongoing regulatory obligations and oversight impacting MindMed's Products, research and clinical programs, and business, including those relating to patient privacy; uncertainty of market acceptance and commercial success of MindMed's Products and product candidates and the impact of studies (whether conducted by MindMed or others and whether mandated or voluntary) on the commercial success of MindMed's Products and product candidates; the availability and extent of reimbursement of MindMed's Products from third-party payers, including private payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and government programs such as Medicare and Medicaid; coverage and reimbursement determinations by such payers and new policies and procedures adopted by such payers; competing drugs and product candidates that may be superior to MindMed's Products and product candidates; the extent to which the results from the research and development programs conducted by MindMed or its collaborators may be replicated in other studies and lead to therapeutic applications; the ability of MindMed to manufacture and manage supply chains for multiple products and product candidates; the ability of MindMed's collaborators, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labelling, distribution, and other steps related to MindMed's Products and product candidates; unanticipated expenses; the costs of developing, producing, and selling products; the ability of MindMed to meet any of its financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license or collaboration agreement to be cancelled or terminated without any further product success; and risks associated with intellectual property of other parties and pending or future litigation relating thereto, other litigation and other proceedings and government investigations relating to the Company and/or its operations, the ultimate outcome of any such proceedings and investigations, and the impact any of the foregoing may have on MindMed's business, prospects, operating results, and financial condition. Any forward-looking statements are made based on management's current beliefs and judgment, and the reader is cautioned not to rely on any forward-looking statements made by MindMed. MindMed does not undertake any obligation to update publicly any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise.

Media Contact: Anna Walsh
E: mindmedpr@pacepublicrelations.com
P: 212-254-4730

Investor Relations: invest@mindmed.co

SOURCE Mind Medicine (MindMed) Inc.
Related Links

https://www.mindmed.co/


Organization Profile

Mind Medicine (MindMed) Inc.


Also from this source


MindMed Developing IP For Personalized Psychedelic Assisted...


MindMed To Evaluate Ayahuasca's Active Ingredient DMT In Phase 1...


Phase 2 Clinical Trial of LSD for "Suicide Headaches" Begins...

HUAWEI QUOTES BOLTONNew book reveals Trump sees Meng arrest as about leverage, not justice

Huawei Canada

Statement from Huawei Canada:

MARKHAM, ON, June 28, 2020 /CNW/ - The new book by Donald Trump's former National Security Advisor reveals that, from the start, the President of the United States viewed the arrest and detention of Meng Wanzhou, Chief Financial Officer of Huawei, as a way of exerting political leverage – not as a matter of justice.

In The Room Where it Happened, John Bolton writes: "At the December 7 [2018] White House Christmas dinner, Trump raised Meng's arrest, riffing about how much pressure this put on China."

According to Bolton, Trump viewed Ms. Meng as a prominent Chinese citizen – "the Ivanka Trump of China," in the President's words – whose freedom could be a powerful bargaining chip in trade negotiations with China. As Bolton puts it: "…Trump believed everything was open in trade negotiations."

Bolton's recollection of events is supported by Trump's own public comments days after Ms. Meng's arrest: He said he would interfere politically in the case if it helped the U.S.-China relationship. "If I think it's good for what will be certainly the largest trade deal ever made – which is a very important thing – what's good for national security, I would certainly intervene if I thought it was necessary," the President said in December 2018.

In Donald Trump's eyes the charges against Ms. Meng have always been a bargaining chip to be used to negotiate a trade deal with China and enhance his chances at re-election in November.

This reckless and unethical perspective has left the government of Canada in an extremely difficult situation – caught in the middle of an escalating dispute between two global powers.

It is the duty of the President of the United States to uphold the law – not to manipulate it for his own political benefit. We call on the Trump administration to immediately withdraw the charges against Meng Wanzhou.

SOURCE Huawei Canada

Organization Profile

Huawei Canada


Also from this source


Huawei Canada spokesperson provides the following statement...


Huawei Statement Regarding the UK Government's 5G Decision...


Huawei Canada Statement Regarding Meng Wanzhou Cas

FUEL CELLS (CDN) VS ELECTRIC (TESLA)

Ballard Applauds Landmark Zero-Emission Trucks Regulation in California 

Ballard Power Systems Inc.

Fuel cell solutions offer a compelling value proposition for trucks

VANCOUVER, BC, June 29, 2020 /CNW/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today recognized the landmark Advanced Clean Truck Regulation passed by the California Air Resources Board (CARB), requiring the scaled adoption of zero-emission commercial trucks in California.

On June 25, 2020 CARB adopted a first-in-the-world regulation requiring truck manufacturers to transition from diesel trucks and vans (for Class 2b through Class 8) to electric zero-emission trucks, with a plan for every new truck sold in California to be zero-emission by 2045.

Manufacturers who certify medium- and heavy-duty chassis or complete vehicles with combustion engines are now required to sell zero-emission trucks as an increasing percentage of their annual sales in California, starting in 2024. For model year 2024, 9% of all on-road Class 4-8 truck sales must be zero-emission vehicles, incrementally scaling up to 50% for 2030, and 75% for 2035 and beyond. Similarly, for Class 7-8 tractors the requirements are 5% for 2024, 30% for 2030, and 40% for 2035.

Sales requirements for Class 7-8 tractors under this regulation create alignment with the Clean Air Action Plan encompassing the Ports of Los Angeles and Long Beach, which has a goal of reducing pollution from every source at the ports. Sources include ships, trains, harbor craft, cargo-handling equipment, along with 16,000 Class 8 drayage trucks currently operating at these ports.

"This bold zero-emission trucks regulation recognizes that, although trucks represent just 7% of all registered vehicles in California, they are responsible for 70% of the state's smog-causing pollution and 80% of carcinogenic diesel soot," said Randy MacEwen, Ballard President and CEO. "The Advanced Clean Truck Regulation puts California on an aggressive path toward implementation of clean energy transportation solutions for medium and heavy-duty trucks – market segments for which emissions abatement has previously proven difficult to achieve. We believe hydrogen-powered fuel cells will uniquely enable the decarbonization of heavy and long-range commercial trucks, with clear range and refueling advantages over battery electric trucks and without compromises to payload."

Tim Sasseen, Ballard's Business Development Manager for California stated, "We commend CARB for its continued strong leadership in reducing emissions and improving air quality. At Ballard, we are dedicated to offering a compelling portfolio of fuel cell products to accelerate the commercialization of fuel cell trucks in California. We are initially focused on market segments that feature heavy trucks with long daily range requirements and a return-to-base depot refueling model, with longer-term markets that feature corridor refueling. We are making progress on current and planned fuel cell truck demonstration programs to support California in meetings its zero-emission trucks mandates."

Ballard's industry leading fuel cell technology currently supports the operation of over 2,200 commercial trucks, primarily in China. Ballard estimates the total global addressable market for fuel cell engines in commercial trucks at more than $120 billion annually.

About Ballard Power Systems
Ballard Power Systems' (NASDAQ: BLDP;TSX: BLDP) vision is to deliver fuel cell power for a sustainable planet. Ballard zero-emission PEM fuel cells are enabling electrification of mobility, including buses, commercial trucks, trains, marine vessels, passenger cars, forklift trucks and UAVs. To learn more about Ballard, please visit www.ballard.com.

This release contains forward-looking statements concerning anticipated product performance and other characteristics, product deliveries and deployments. These forward-looking statements reflect Ballard's current expectations as contemplated under section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any such forward-looking statements are based on Ballard's assumptions relating to its financial forecasts and expectations regarding its product development efforts, manufacturing capacity, and market demand.

These statements involve risks and uncertainties that may cause Ballard's actual results to be materially different, including general economic and regulatory changes, detrimental reliance on third parties, successfully achieving our business plans and achieving and sustaining profitability. For a detailed discussion of these and other risk factors that could affect Ballard's future performance, please refer to Ballard's most recent Annual Information Form. Readers should not place undue reliance on Ballard's forward-looking statements and Ballard assumes no obligation to update or release any revisions to these forward looking statements, other than as required under applicable legislation.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities. The Ballard Common Shares have not been registered under the United States Securities Act of 1933, as amended, or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

SOURCE Ballard Power Systems Inc.

For further information: Guy McAree, +1.604.412.7919, media@ballard.com or investors@ballard.com
Related Links

www.ballard.com


Organization Profile



Ballard Power Systems Inc.